상세 보기
Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial
- Kim, H.;
- Park, S.;
- Kim, T. M.;
- Han, J-Y.;
- Lee, G-W.;
- 외 12명
Citations
WEB OF SCIENCE
0- 제목
- Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial
- 저자
- Kim, H.; Park, S.; Kim, T. M.; Han, J-Y.; Lee, G-W.; Shim, B. Y.; Lee, Y-G.; Kim, S-W.; Ock, C-Y.; Hwang, S.; Lee, Y.; Kim, R.; Jung, H. A.; Sun, J-M.; Lee, S-H.; Ahn, J. S.; Ahn, M-J.
- 발행일
- 2024-12
- 유형
- Meeting Abstract
- 권
- 35
- 페이지
- S1636 ~ S1636